Apple has filed a lawsuit against OpenAI, accusing the company and former employees of stealing proprietary trade secrets. The legal action signals escalating IP disputes in the AI sector and raises questions about talent mobility and confidentiality agreements at AI labs. For healthcare AI stakeholders, this case underscores critical compliance and security risks when deploying foundation models in clinical environments where data protection and model integrity are non-negotiable. Health systems and vendors integrating OpenAI technology should review their data-sharing agreements and evaluate the legal exposure of proprietary clinical workflows built on third-party AI platforms. This precedent may influence how healthcare organizations approach vendor selection and contractual protections for AI systems handling sensitive patient data.